First Quadrant’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

First Quadrant’s Portfolio CSLT Stock Details CSLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-80,800	Closed	-$124K	–	568
2021 Q4	$124K	Sell	80,800 -17,460	-18%	-$28.8K	0.01%	370
2021 Q3	$154K	Buy	98,260 +2,501	+3%	+$4.9K	0.02%	357
2021 Q2	$252K	Sell	95,759 -11,811	-11%	-$22K	0.03%	319
2021 Q1	$162K	Buy	107,570 +91,404	+565%	+$159K	0.02%	377
2020 Q4	$21K	Buy	+16,166	New	+$18.2K	﹤0.01%	522
2019 Q3	–	Sell	-19,326	Closed	-$62K	–	701
2019 Q2	$62K	Buy	+19,326	New	+$66.6K	﹤0.01%	619
2018 Q2	–	Sell	-18,704	Closed	-$68K	–	868
2018 Q1	$68K	Sell	18,704 -25,833	-58%	-$95.8K	﹤0.01%	718
2017 Q4	$167K	Buy	+44,537	New	+$178K	﹤0.01%	757

First Quadrant's CSLT Position: Q1 2022 in Review

First Quadrant sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 80,800 shares — an estimated $124K sold.

First Quadrant first reported a position in CSLT in Q4 2017 and held it in 8 quarters. The position peaked at $252K in Q2 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

First Quadrant reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 80,800 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $124K.
First Quadrant first reported a position in CASTLIGHT HEALTH, INC. in Q4 2017 and held it in 8 quarters.
First Quadrant's CASTLIGHT HEALTH, INC. position peaked at $252K in Q2 2021.
0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.